Innovation at ICON is focused on the factors that are critical to our clients. We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs, providing true transparency across all areas of a study.
An informatics platform to analyse the operational, clinical and real world data collected during clinical development.
Connecting patients with the right trial in the right location.
Improving site selection and study start-up.
Digital solutions improving the clinical trial experience for sites, patients and study staff.
Intel and ICON: Digitizing together clinical trials with Intel® Pharma Analytics Platform, an edge-to-cloud AI solution for remote monitoring and continuous capture of clinical data using sensors and wearable devices.
A cloud-based system featuring automated and configurable business rules to ensure regulatory compliance and provide visibility into the safety profile of an investigational product throughout its lifecycle.
ADDPLAN is a regulatory validated design, simulation and analysis software platform for adaptive clinical trials.
Interactive Response Technology (IRT) platform for managing patient randomisation, investigator sites, and clinical supplies.
A central repository and analytic platform for all of your RWD assets.
ICON’s nonlinear mixed effects modelling tool, the industry standard for population PK/PD analysis.
PDx-POP is ICON’s software tool for expediting the iterative process of population pharmacokinetic modeling and analysis.
Streamling the management of images in clinical trials.
ICOLabs™ Medical Review Application (IMRA) is a web based laboratory data review application that provides global access to client’s study.
PubsHub software streamlines and automates your medical and scientific communications and publication management.